Toxikon

Preclinical Contract Research Servicestoxikon.com

Company typePublic
Founded1976
HeadquartersBedford, United States
Headcount101–250
GTM typeB2B
OfferingServices

Toxikon firmographics

Firmographics

Name: Toxikon
Legal name: Laboratory Corporation of America Holdings
Website: https://toxikon.com
Company type: Public
Founded year: 1976
Operating status: Operating
Headcount range: 101–250 employees
Ownership category
akta.pro rank

Toxikon industry classification

Industry

Product category: Preclinical Contract Research Services
NAICS: Testing Laboratories and Services (541380)
SIC: Services-Commercial Physical & Biological Research (8731)
akta.pro primary industry: Nonclinical Study Management & Regulatory Writing (IND-enabling) (HLAGAFAN)
akta.pro secondary industry: Quality Engineering & Risk Management (ICH Q9/Q10, validation, change control) (HLAGAKAL)

Keywords

Preclinical contract research
Medical device testing
Pharmaceutical safety assessment
Toxicology research services
Product development studies

Where Toxikon is headquartered

Location

Headquarters

HQ city: Bedford
HQ country: United States
HQ region: North America

Offices2 records

Markets served

Toxikon business model

Business model

GTM type: B2B
Offering type: Services
Cost components: Personnel, Operations, Technology or R&D, Infrastructure

Revenue model

Clinical Laboratory Testing: Diagnostic testing services for patients through physician orders, hospital systems, and direct consumer access. Services include routine labwork, specialty testing, genetic testing, and disease-specific diagnostics across multiple therapeutic areas including oncology, neurology, rheumatology, and women's health.
Biopharma Services: Comprehensive drug development services including nonclinical development, central laboratory services, early phase development, regulatory consulting, and commercialization support for pharmaceutical companies worldwide.
Labcorp OnDemand: Direct-to-consumer at-home testing kits and patient service center testing available without physician order. Includes over 50 self-ordered lab tests for wellness monitoring, with subscription options for certain offerings.
Employer & Organization Services: Workplace drug testing, employee wellness programs, biometric screenings, health coaching, and population health management services for employers and organizations.

Pricing tiers

Model	Billing	Price
Unit Pricing	Pay-as-you-go	Labcorp OnDemand - Individual Tests
Subscription	Monthly	Labcorp OnDemand - Subscriptions

Go-to-market motion2 records

Distribution channels5 records

Marketing channels5 records

Toxikon product offering

Product offering

Core offering

Toxikon is a preclinical contract research organization delivering product development services from concept to final product. The firm conducts safety, toxicology, and efficacy studies to support pharmaceutical, biotechnology, and medical device developers in advancing their products through preclinical stages of development.

Differentiator

Problem solved

Functional benefit

Brands

Labcorp OnDemand: Self-ordered lab testing service allowing patients to access 50+ tests, including at-home kits and tests at patient service centers
MyLabcorp
Labcorp Diagnostic Assistant
Labcorp Link
Labcorp Venture Fund
Ovia Health
Labcorp OnDemand

Products and services

Preclinical Product Development Services

Quantifiable outcome

Over 85% of new drugs and therapeutic products approved by the U.S. FDA were supported by Labcorp
+1 more outcomes

Companies that use Toxikon

Customer profile

Named customers2 records

Segments5 records

Ideal customer profiles2 records

Toxikon technology and API

Technology

Technology focussed No

API detail

Has API: No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

Toxikon partnerships and signals

Strategic signal

Partnerships

Five partnerships are on record, tiered core and minor.

Amazon Web Services (AWS)coreTechnology or IntegrationAWS provides cloud infrastructure for Labcorp's AI-powered real-world data platform for Alzheimer's disease, developed in partnership to deliver longitudinal laboratory data at scale with advanced analytics.
DatavantcoreTechnology or IntegrationDatavant partners with Labcorp to enable the AI-powered real-world data platform, providing data connectivity capabilities for longitudinal patient data analysis.
WalgreenscoreChannel Partner/ Reseller/ DistributorHundreds of Walgreens pharmacy locations offer Labcorp sample collection services, providing convenient retail access points for patients.
InvitaecoreStrategic or Co-development PartnerLabcorp acquired Invitae, a genetic testing company, welcoming the Invitae team as scientific leaders in the development and adoption of genetic testing.
Ovia HealthminorStrategic or Co-development PartnerPartnership for women's health resources including pregnancy, fertility, parenting, and menopause apps integrated with Labcorp testing services.

Scale indicators5 records

Recent moves2 records

Expansion highlights3 records

Toxikon competitors and assessment

Company assessment

Broad incumbents

PPD (Thermo Fisher Scientific): PPD, now part of Thermo Fisher Scientific, is a top-five global CRO with preclinical, clinical, and laboratory services. Comparable to Toxikon as a scaled full-service CRO competitor for biopharma development programs.
IQVIA: IQVIA is the largest global CRO with broad preclinical, clinical, and real-world data capabilities. Relevant as a large incumbent that bids for the same end-to-end biopharma development contracts that can include Toxikon's preclinical scope.
Labcorp Drug Development: Labcorp Drug Development is the broader CRO arm of Toxikon's parent, offering early-phase clinical development, central lab, and bioanalytical services. As Toxikon's own parent business, it bundles Toxikon's preclinical capabilities into integrated offerings spanning preclinical through clinical.
ICON plc: ICON is a top-tier global CRO offering preclinical through Phase IV services, including laboratory and bioanalytical capabilities. Comparable to Toxikon at the preclinical end of ICON's full-service portfolio, often competing for the same biopharma clients.

Direct peers

WuXi AppTec: WuXi AppTec operates a large preclinical and toxicology service line within its broader CRO platform. Highly comparable to Toxikon on preclinical study design, DMPK, and IND-enabling work, with significant global biotech client overlap.
Charles River Laboratories: Charles River is the largest dedicated preclinical CRO globally, offering toxicology, DMPK, and safety assessment services directly comparable to Toxikon's core IND-enabling offerings. The closest direct competitor for outsourced preclinical study awards.
Eurofins Scientific: Eurofins is a global contract laboratory group with significant preclinical, toxicology, and product-safety testing capabilities serving pharma, chemical, and consumer-products clients. Directly comparable to Toxikon's preclinical product safety testing scope.
Intertek: Intertek provides contract laboratory and product testing services across pharma, chemical, and consumer-products industries. Overlaps with Toxikon on regulated safety/toxicology testing for product development programs.
SGS SA: SGS is a global testing, inspection, and certification company with a life sciences CRO arm offering preclinical safety and product testing. Directly comparable to Toxikon on regulated product safety and contract laboratory services.

Regional players

Pace Analytical Services: Pace Analytical is a U.S.-focused contract laboratory providing life sciences, environmental, and product safety testing. Comparable to Toxikon on regulated product safety testing, with primary U.S. geographic overlap.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights5 records

Customer concentration

Toxikon financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Toxikon leadership team

Management profile

Number of profiles

Profiles2 records

Toxikon subsidiaries and ownership

Company hierarchy

Subsidiaries22 records

Toxikon funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Toxikon M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Toxikon

What does Toxikon do?

Is Toxikon a public or private company?

Toxikon is a public company. It is classified as corporate owned and is currently operating.

When was Toxikon founded?

Toxikon was founded in 1976. It employs 101 to 250 people.

Where is Toxikon based?

Toxikon is headquartered in Bedford, United States, in the North America region.

How does Toxikon make money?

Four revenue lines are on record. Clinical Laboratory Testing is the primary driver. The others are biopharma Services, labcorp OnDemand and employer & Organization Services.

Who are Toxikon's main competitors?

Broad incumbents on record are PPD (Thermo Fisher Scientific), IQVIA, Labcorp Drug Development and ICON plc. Direct peers are WuXi AppTec, Charles River Laboratories, Eurofins Scientific, Intertek and SGS SA. Pace Analytical Services is listed as a regional player.

Does Toxikon have an API?

No public API is recorded for Toxikon.

What industry is Toxikon in?

Toxikon's product category is Preclinical Contract Research Services. Its primary akta.pro industry code is HLAGAFAN, Nonclinical Study Management & Regulatory Writing (IND-enabling), with a secondary code of HLAGAKAL, Quality Engineering & Risk Management (ICH Q9/Q10, validation, change control). Its NAICS code is 541380 and its SIC code is 8731.